Article info
PDFResearch
Original article
Patient safety in drug label design: analysis of reported adverse events before and after introducing a new label design
- Correspondence to Dr Annemarie Hellebek, Unit for Patient Safety Capital Region of Denmark and Danish Society for Patient Safety, P610, Hvidovre Hospital, Kettegaard Allé 30, Hvidovre, Copenhagen DK-2650, Denmark; Annemarie.hellebek{at}regionh.dk
Citation
Patient safety in drug label design: analysis of reported adverse events before and after introducing a new label design
Publication history
- Received January 3, 2013
- Revised April 23, 2013
- Accepted April 25, 2013
- First published June 11, 2013.
Online issue publication
November 11, 2020
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online figure 1
- Data supplement 2 - Online figure 2
- Data supplement 3 - Online figure 3
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions